Contact Edwin

Edwin Park

is a Research Professor at the Georgetown University McCourt School of Public Policy’s Center for Children and Families.

Edwin Park is a Research Professor at the Georgetown University McCourt School of Public Policy.  His work primarily focuses on Medicaid, the Children’s Health Insurance Program (CHIP) and the Affordable Care Act and he is considered one of the nation’s leading health policy experts on issues related to Medicaid and CHIP financing and the Affordable Care Act’s coverage expansions, among others.  He also analyzes tax policies related to health care and policies related to drug pricing and private insurance markets.

He has testified before Congress and the California state legislature, been interviewed by media outlets such as National Public Radio and CNBC, and has been cited in numerous print publications including The New York Times, The Washington Post, The Wall Street Journal, the Los Angeles Times, the San Francisco Chronicle and the Chicago Tribune and in digital media such as Politico, Vox, HuffPost and Kaiser Health News.

Previously, he worked for 17 years at the Center on Budget and Policy Priorities, a non-partisan, non-profit research and policy organization based in Washington D.C. that focuses on fiscal policy and policies affecting low- and moderate-income individuals and families at both the federal and state levels.  Most recently, he was Vice President for Health Policy, co-directing the Center’s 15-person health policy team.

He also served as the health policy advisor for the National Economic Council at the White House during the Clinton Administration and as a Medicaid professional staff member for the U.S. Senate Finance Committee, as part of the minority staff of then-Ranking Member Senator Daniel Patrick Moynihan.  He also was an attorney in private practice, as part of the Health Practice Group at Hogan & Hartson (now Hogan Lovells).

He also recently served on the Biden-Harris Presidential Transition Agency Review Team for the U.S. Department of Health and Human Services.  He is a member of the National Academy of Social Insurance.

He has a J.D., magna cum laude, from Harvard Law School, where he was an editor of the Harvard Law Review.  He also has an A.B. in Public and International Affairs, summa cum laude and Phi Beta Kappa, from Princeton University.

Latest From Edwin

Assessing the Potential Impact of the Inflation Reduction Act on Federal and State Medicaid Prescription Drug Spending

The Inflation Reduction Act (P.L. 117-169) did not include any drug pricing provisions directly affecting Medicaid.  But as I have previously written for the Commonwealth Fund, Medicare drug pricing reforms can interact with the highly effective Medicaid Drug Rebate Program, under which drug manufacturers must pay sizable rebates to state Medicaid programs that significantly lower […]

Congress Could Consider Medicaid and CHIP Drug Pricing Provisions

The Inflation Reduction Act (P.L. 117-169), signed into law on August 16, 2022, includes historic Medicare drug pricing provisions such as a requirement for Medicare to directly negotiate prices with drug manufacturers for certain high-cost drugs and a requirement that drug manufacturers pay rebates to Medicare if their prices rise faster than inflation. Unfortunately, the […]

CCF Submits Comments to Proposed Rule Fixing the Family Glitch

On June 2, 2022, CCF submitted public comments to the Internal Revenue Service related to a proposed rule which would finally fix the “family glitch.”  As my colleague Tricia Brooks recently explained, the family glitch makes many children and other dependents in families offered unaffordable employer-based family coverage ineligible for premium tax credits to purchase […]